NAGASE (EUROPA) GmbH

NAGASE (EUROPA) GmbH

About

Company description

Established in 1832, net sales of US $7 billion, Japan-based trading house having manufacturing companies of finished dosage form (FDF) and excipient. 
[Nagase Medicals Co., Ltd] A sterile FDF manufacturer, dedicated to production of injectables & liposomal dosage and specialized in oncology filed. 
[Hayashibara Co., Ltd] The world largest commercial manufacturer of saccharide-base excipients (Trehalose, Maltose and Pullulan).



Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Distributor; Exporter; Importer; Trading Company
Affiliated categories: APIs |Enzymes |Food Additive More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 102A14 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 8C100 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 102B113 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with NAGASE (EUROPA) GmbH

NAGASE (EUROPA) GmbH

Contact information

Address

Telephone

Website

View all contact information